Impairment Loss on Investment Securities for New Business Creation
First written in FY2018-Q3. 7 of 9 entries say "Mitigated", first in FY2019-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2026: 35 of 81 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「During the current consolidated fiscal year, the Company recognized impairment losses of ¥0 million on securities, comprising ¥0 million on shares and other assets classified as other securities.」
Impairment losses on investment securities declined from ¥18 million in the previous fiscal year to ¥0 million in the current fiscal year, eliminating the impact of investment losses on results. The Investment Committee’s policy for deciding whether to invest and monitoring investments after they are made remains in place. - 2026-05-22MitigatedGeneral Meetings of Shareholders
「Loss on valuation of investment securities 0」
The consolidated income statement confirms that no loss on valuation of investment securities was incurred during the consolidated fiscal year under review. - FY2024MitigatedAnnual report
「During the current consolidated fiscal year, the Company recognized impairment losses of ¥26 million on securities, comprising ¥26 million on shares and other assets classified as other securities.」
Impairment losses on investment securities declined from ¥178 million in the previous fiscal year to ¥26 million, reducing the impact of investment losses associated with developing new products and suppliers. However, an impairment loss was still recorded in the current fiscal year. - FY2020MitigatedAnnual report
「Current consolidated fiscal year (1 April 2019 to 31 March 2020): No applicable items.」
Although an impairment loss of ¥220 million on investment securities was recorded in the previous fiscal year, no impairment losses were recognized in the current consolidated fiscal year. Pre-investment screening and post-investment monitoring remain in place. - FY2020-Q3MitigatedAnnual report
「Impairment loss on investment securities 5 —」
Impair losses on investment securities declined from ¥5 million in the same period of the previous year to ¥0 million in the cumulative third-quarter period, with no impairment loss recorded for the period. - FY2019MitigatedAnnual report
「During the current consolidated fiscal year, the Company recognized impairment losses of ¥220 million on securities, comprising ¥220 million on shares classified as other securities.」
Impairment losses on investment securities declined from ¥467 million in the previous fiscal year to ¥220 million. However, an impairment loss was still incurred in the current fiscal year. - FY2019-Q3MitigatedAnnual report
「Impairment loss on investment securities 215 5」
Impairment losses on investment securities declined from ¥215 million in the same period of the previous year to ¥5 million in the cumulative third-quarter period. However, an impairment loss was still recorded. - FY2018WorsenedAnnual report
「During the current consolidated fiscal year, the Company recognized impairment losses of ¥467 million on securities, comprising ¥467 million on shares and other assets classified as other securities.」
In addition to the ¥215 million impairment loss on investment securities for new businesses identified in the third quarter, full-year impairment losses on securities increased to ¥467 million. The full-year disclosure does not specify that the entire amount arose from new business investment. - FY2018-Q3MaterialisedAnnual report
「During the third quarter of the fiscal year, the Company also recognized an impairment loss on investment securities of ¥215 million as an extraordinary loss for part of the investment securities acquired to create new businesses.」
An impairment loss of ¥215 million was incurred on part of the investment securities acquired for new business creation and was recorded as an extraordinary loss.